CN102127093A - Refining process for Cefotiam hexetil hydrochloride - Google Patents
Refining process for Cefotiam hexetil hydrochloride Download PDFInfo
- Publication number
- CN102127093A CN102127093A CN2010106004012A CN201010600401A CN102127093A CN 102127093 A CN102127093 A CN 102127093A CN 2010106004012 A CN2010106004012 A CN 2010106004012A CN 201010600401 A CN201010600401 A CN 201010600401A CN 102127093 A CN102127093 A CN 102127093A
- Authority
- CN
- China
- Prior art keywords
- cefotiam
- salt
- hexetil
- add
- carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229950010227 cefotiam hexetil Drugs 0.000 title claims abstract description 94
- VVFDMWZLBPUKTD-ZKRNHDOASA-N cefotiam hexetil ester Chemical compound O=C([C@@H](NC(=O)CC=1N=C(N)SC=1)[C@H]1SCC=2CSC=3N(N=NN=3)CCN(C)C)N1C=2C(=O)OC(C)OC(=O)OC1CCCCC1 VVFDMWZLBPUKTD-ZKRNHDOASA-N 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims abstract description 43
- 238000007670 refining Methods 0.000 title claims abstract description 16
- QYQDKDWGWDOFFU-IUODEOHRSA-N Cefotiam Chemical compound CN(C)CCN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC=3N=C(N)SC=3)[C@H]2SC1 QYQDKDWGWDOFFU-IUODEOHRSA-N 0.000 claims abstract description 85
- 229960001242 cefotiam Drugs 0.000 claims abstract description 78
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000003960 organic solvent Substances 0.000 claims abstract description 24
- 230000032050 esterification Effects 0.000 claims abstract description 23
- 238000005886 esterification reaction Methods 0.000 claims abstract description 23
- 239000007789 gas Substances 0.000 claims abstract description 23
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 94
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 69
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 34
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 27
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 26
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 24
- -1 cefotiam sodium salt Chemical class 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 22
- 238000000967 suction filtration Methods 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 17
- 239000001103 potassium chloride Substances 0.000 claims description 17
- 235000011164 potassium chloride Nutrition 0.000 claims description 17
- 238000002425 crystallisation Methods 0.000 claims description 16
- 230000008025 crystallization Effects 0.000 claims description 16
- 235000015320 potassium carbonate Nutrition 0.000 claims description 16
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 10
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 235000017550 sodium carbonate Nutrition 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 7
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 claims description 7
- 238000009423 ventilation Methods 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- 235000011181 potassium carbonates Nutrition 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-N sodium;hydron;carbonate Chemical compound [Na+].OC(O)=O UIIMBOGNXHQVGW-UHFFFAOYSA-N 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 abstract description 9
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 159000000000 sodium salts Chemical class 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- TYBWWPALTFYPIQ-UHFFFAOYSA-N 1-bromoethyl cyclohexyl carbonate Chemical compound CC(Br)OC(=O)OC1CCCCC1 TYBWWPALTFYPIQ-UHFFFAOYSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000012065 filter cake Substances 0.000 description 8
- 239000000376 reactant Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000010907 mechanical stirring Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000012043 crude product Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229940127249 oral antibiotic Drugs 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000011182 sodium carbonates Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010048946 Anal abscess Diseases 0.000 description 1
- 108010065152 Coagulase Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229960003311 ampicillin trihydrate Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010600401 CN102127093B (en) | 2010-12-22 | 2010-12-22 | Refining process for Cefotiam hexetil hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010600401 CN102127093B (en) | 2010-12-22 | 2010-12-22 | Refining process for Cefotiam hexetil hydrochloride |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102127093A true CN102127093A (en) | 2011-07-20 |
CN102127093B CN102127093B (en) | 2013-03-20 |
Family
ID=44265394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010600401 Expired - Fee Related CN102127093B (en) | 2010-12-22 | 2010-12-22 | Refining process for Cefotiam hexetil hydrochloride |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102127093B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104031068A (en) * | 2014-06-11 | 2014-09-10 | 济南诚汇双达化工有限公司 | Method of preparing cefotiam hexetil hydrochloride by one-pot method |
CN106749334A (en) * | 2016-11-23 | 2017-05-31 | 扬子江药业集团北京海燕药业有限公司 | A kind of preparation method of high-purity cefotiam hexetil dihydrochloride |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101619069A (en) * | 2009-07-28 | 2010-01-06 | 余小强 | Preparation method of cefotiam hexetil hydrochloride |
-
2010
- 2010-12-22 CN CN 201010600401 patent/CN102127093B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101619069A (en) * | 2009-07-28 | 2010-01-06 | 余小强 | Preparation method of cefotiam hexetil hydrochloride |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104031068A (en) * | 2014-06-11 | 2014-09-10 | 济南诚汇双达化工有限公司 | Method of preparing cefotiam hexetil hydrochloride by one-pot method |
CN106749334A (en) * | 2016-11-23 | 2017-05-31 | 扬子江药业集团北京海燕药业有限公司 | A kind of preparation method of high-purity cefotiam hexetil dihydrochloride |
Also Published As
Publication number | Publication date |
---|---|
CN102127093B (en) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106810426B (en) | Method for synthesizing cannabidiol | |
CN107778223B (en) | Preparation method of betrixaban maleate | |
CN101619069A (en) | Preparation method of cefotiam hexetil hydrochloride | |
CN105814020A (en) | Substituted nicotinamide derivatives as kinase inhibitors | |
CN106279104B (en) | A kind of process modification method preparing amber love song Ge Lieting | |
CN103554201A (en) | Gamithromycin preparation method | |
CN110183367A (en) | A kind of synthetic method of (3R, 4S) -1- benzyloxycarbonyl group -4- N-ethyl pyrrole N -3- carboxylic acid suitable for industrialization | |
CN101475539B (en) | Refining method for preparing high-purity oteracil potassium | |
CN106977512A (en) | The method for preparing the smooth free alkali of horse sieve | |
CN102127093B (en) | Refining process for Cefotiam hexetil hydrochloride | |
CN109694359B (en) | Synthetic method of nitrofuran metabolite-furazolidone AOZ-D4 | |
CN106674084A (en) | Preparation method of 2-isopropoxy-5-methyl-4-(piperidine-4-yl) aniline dihydrochloride | |
CN101990528B (en) | Catechol manufacturing method | |
CN103254156A (en) | Preparation method of afatinib intermediate | |
CN105745191A (en) | Method for preparing silodosin and intermediate thereof | |
CN111100042B (en) | Preparation method of 2-methoxy-5-sulfonamide benzoic acid | |
CN106674205A (en) | Sartan compound discoloration method | |
CN103923135B (en) | A kind of deuterated 5-hydroxyl color D-glucosamine glycoside derivates and preparation method thereof | |
CN110305074B (en) | Synthesis method of quaternary ammonium salt-73 | |
CN101735296B (en) | Method for preparing fludarabine | |
CN101492388A (en) | Method for synthesis of Miqujing medicament material | |
CN113248465B (en) | Synthetic method of biochanin A | |
EP3026047A1 (en) | Method for producing heterocyclic compound | |
CN109651234A (en) | A kind of synthetic method of Doneppezil Hydrochloride | |
CN104447528B (en) | The preparation method of pyridine-2,3-diethyl dicarboxylate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU HANSES PHARMACEUTICAL RESEARCH + DEVELOP Free format text: FORMER OWNER: XU JIAXIANG Effective date: 20130122 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 150001 HARBIN, HEILONGJIANG PROVINCE TO: 510330 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130122 Address after: 205, room 510330, Haizhu science and technology building, 2429 East Xingang Road, Guangzhou, Guangdong Applicant after: Guangzhou Hanses Pharmaceutical Research & Development Co., Ltd. Address before: 150001, Ma 302 street, Nangang District, Heilongjiang, Harbin Applicant before: Xu Jiaxiang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: XIZANG HANSES PHARMACEUTICAL DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: GUANGZHOU HANSES PHARMACEUTICAL RESEARCH + DEVELOPMENT CO., LTD. Effective date: 20140722 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510330 GUANGZHOU, GUANGDONG PROVINCE TO: NYINGCHI PREFECTURE, TIBET AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140722 Address after: No. 31 east section of Fuzhou Road, Linzhi District, Tibet Tibetan Autonomous Region Patentee after: Tibet and rattan pharmaceutical development Limited by Share Ltd Address before: 205, room 510330, Haizhu science and technology building, 2429 East Xingang Road, Guangzhou, Guangdong Patentee before: Guangzhou Hanses Pharmaceutical Research & Development Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Tibet and rattan pharmaceutical development Limited by Share Ltd Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Tibet and rattan pharmaceutical development Limited by Share Ltd Document name: Notification of Termination of Patent Right |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130320 Termination date: 20181222 |
|
CF01 | Termination of patent right due to non-payment of annual fee |